Safety of Ixazomib targeting plasma cells in multiple sclerosis

Authors
Category Primary study
JournalEuropean Journal of Neurology
Year 2020
This article has no abstract
Epistemonikos ID: d50f1039779a0b2099bcf0639d0e57940b36c7af
First added on: Feb 12, 2025